Effect of the Baseline Use of Angiotensin-Converting Enzyme Inhibitors (ACEIs) or Angiotensin-Receptor Blockers (ARBs) on Outcomes of Patients With Suspected or Positive COVID-19 Infection

被引：0
|
作者：
Muhlestein, Joseph B.
Knowlton, Kirk U.
May, Heidi T.
Knight, Stacey
Bair, Tami L.
Le, Viet T.
Horne, Benjamin D.
Anderson, Jeffrey L.
机构：
来源：
CIRCULATION | 2020年 / 142卷
关键词：
D O I：
10.1161/circ.142.suppl_3.16745
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A16745
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Protective effect of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor antagonists (ARBs) on microalbuminuria in diabetic patients
    Elsafa, Enas
    Ali, Pirzado Zahid
    CLINICAL DIABETOLOGY, 2020, 9 (03): : 193 - 200
  • [22] COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers What Is the Evidence?
    Patel, Ankit B.
    Verma, Ashish
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (18): : 1769 - 1770
  • [23] Angiotensin-Converting Enzyme Inhibitors (ACEIs) or Angiotensin-Receptor Blockers (ARBs) during CF-LVAD Support Are Associated with Sustained Improvement in Renal Function
    Saeed, O.
    Jermyn, R.
    Patel, S.
    Shin, J.
    D'Alessandro, D.
    Goldstein, D. J.
    Zolty, R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (04): : S59 - S60
  • [24] Effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the short-term prognosis of COVID-19 infection
    Esteban-Lucia, L.
    Zambrano Chacon, M. A.
    Venegas Rodriguez, A. M.
    Devesa-Arbiol, A.
    Gonzalez-Rodriguez, M.
    Maure-Blesa, L.
    Avila-Barahona, P.
    Pello-Lazaro, A. M.
    Gonzalez-Lorenzo, O.
    Kallmeyer-Mayor, A. M.
    Fernandez-Roblas, R.
    Villar-Alvarez, F.
    Tunon, J.
    Franco-Pelaez, J. A.
    Acena Navarro, A.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2969 - 2969
  • [25] Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in chronic heart failure
    McClellan, MB
    Loeb, JM
    Clancy, CM
    Francis, GS
    Jacobs, AK
    Kizer, KW
    O'Kane, ME
    Wolk, MJ
    ANNALS OF INTERNAL MEDICINE, 2005, 142 (05) : 386 - 387
  • [26] COVID-19 and Angiotensin-Converting Enzyme Inhibitor/Angiotensin-Receptor Blocker Therapy
    Kussmaul, William G., III
    ANNALS OF INTERNAL MEDICINE, 2020, 173 (03) : 237 - 238
  • [27] Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers and the risk of COVID-19 infection or severe disease: Systematic review and meta-analysis
    Caldeira, Daniel
    Alves, Mariana
    Melo, Ryan Gouveia e
    Antonio, Pedro Silverio
    Cunha, Nelson
    Nunes-Ferreira, Afonso
    Prada, Luisa
    Costa, Joao
    Pinto, Fausto J.
    IJC HEART & VASCULATURE, 2020, 31
  • [28] A Meta-Analysis of the Impact of Using Angiotensin-Converting Enzyme Inhibitors (ACEIs) or Angiotensin II Receptor Blockers (ARBs) on Mortality, Severity, and Healthcare Resource Utilization in Patients with COVID-19
    Li, Ruijuan
    Zhang, Jie
    Ren, Liang
    ADVANCES IN RESPIRATORY MEDICINE, 2025, 93 (01)
  • [29] Assessing the outcomes of prescribing angiotensin converting enzyme inhibitors and angiotensin receptor blockers for COVID-19 patients
    Mekary, Wissam
    Fares, Souha
    Abdulhai, Farah
    Massoud, Gaelle
    Refaat, Marwan
    Mericskay, Mathias
    Booz, George W.
    Zouein, Fouad A.
    HELIYON, 2023, 9 (09)
  • [30] Relating angiotensin-converting enzyme inhibitors or angiotensin receptor blockers with incidence or mortality of COVID-19
    Wong, Martin C. S.
    Wong, Sunny
    Huang, Junjie
    Yan, Bryan
    ESC HEART FAILURE, 2020, 7 (05): : 3119 - 3123
12345